Re assessed by one particular potential open-label study every (LoE four).51 52 AZA (2 mg
Re assessed by 1 prospective open-label study every (LoE four).51 52 AZA (2 mg/kg/day) + GC (1 mg/kg/day) was related with an improvement in systemic symptoms and laboratory measures of…